KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) EBIT (2016 - 2025)

Illumina's EBIT history spans 17 years, with the latest figure at $201.0 million for Q4 2025.

  • For Q4 2025, EBIT rose 14.86% year-over-year to $201.0 million; the TTM value through Dec 2025 reached $806.0 million, up 196.88%, while the annual FY2025 figure was $807.0 million, 196.88% up from the prior year.
  • EBIT reached $201.0 million in Q4 2025 per ILMN's latest filing, down from $227.0 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $741.0 million in Q3 2024 to a low of -$4.0 billion in Q1 2023.
  • Average EBIT over 5 years is -$459.8 million, with a median of $34.5 million recorded in 2021.
  • Peak YoY movement for EBIT: plummeted 1760.23% in 2024, then skyrocketed 247.75% in 2025.
  • A 5-year view of EBIT shows it stood at -$545.0 million in 2021, then plummeted by 571.01% to -$3.7 billion in 2022, then soared by 95.52% to -$164.0 million in 2023, then soared by 206.71% to $175.0 million in 2024, then rose by 14.86% to $201.0 million in 2025.
  • Per Business Quant, the three most recent readings for ILMN's EBIT are $201.0 million (Q4 2025), $227.0 million (Q3 2025), and $214.0 million (Q2 2025).